[Form 4] Hyatt Hotels Corporation Insider Trading Activity

Rhea-AI Filing Summary

Hyatt Hotels Corporation director Susan D. Kronick reported two open-market sales of Class A common stock effected under a Rule 10b5-1 trading plan. On 09/02/2025 she sold 1,500 shares at a weighted-average price of $141.65 (individual sale prices ranged from $141.13 to $142.08) and sold an additional 100 shares at $142.15. Following these transactions the filing shows beneficial ownership of 36,325 shares after the 1,500-share sale and 36,225 shares after the 100-share sale. The filing notes the trades were executed pursuant to a 10b5-1 plan adopted on November 20, 2024, and was signed by an attorney-in-fact on 09/03/2025.

Positive

• Trades executed under a Rule 10b5-1 plan, indicating pre-authorized trading and reduced concerns about opportunistic timing
• Disclosure includes weighted-average price and price range, and offers to provide per-price allocation on request, enhancing transparency
• Filing clearly identifies reporting person as a Director and lists the 10b5-1 plan adoption date (November 20, 2024)

Negative

• Insider sold 1,600 shares, which modestly reduces her beneficial ownership from prior levels
• Form does not itemize the number of shares sold at each specific price; only a weighted-average and range are provided

Insights

Securities Analyst

TL;DR: Director sold 1,600 Hyatt shares under a pre-established 10b5-1 plan, reducing beneficial holdings modestly.

The reported transactions are routine insider sales executed under a Rule 10b5-1 trading plan, which typically mitigates concerns about opportunistic timing. Total shares disposed were 1,600 on 09/02/2025 at prices near $142, with the filing providing weighted-average and explicit price ranges. The reported remaining beneficial ownership figures are consistent with successive disposals. From an investor transparency perspective, the disclosure is complete in listing execution method, plan adoption date, and price ranges, and the filer offers to provide detailed per-price allocation on request.

Corporate Governance Expert

TL;DR: Sales appear compliant and documented under an established trading plan; disclosure includes necessary explanatory footnotes.

The Form 4 discloses that the trades were effected pursuant to a 10b5-1 plan adopted on November 20, 2024, which is the standard mechanism for pre-authorized insider trades. The filer included a weighted-average price and a price range for the transactions and offered to provide granular allocation details upon request, supporting transparency. Signature by an attorney-in-fact is recorded, and the relationship to the issuer is clearly marked as Director. No amendment or additional event information is provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRONICK SUSAN D

(Last) (First) (Middle)

C/O HYATT HOTELS CORPORATION

150 NORTH RIVERSIDE PLAZA

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hyatt Hotels Corp [ H ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/02/2025		S(1)		1,500	D	$141.65(2)	36,325	D
Class A Common Stock	09/02/2025		S(1)		100	D	$142.15	36,225	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.13 to $142.08, inclusive. The reporting person undertakes to provide to Hyatt Hotels Corporation, any security holder of Hyatt Hotels Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

	Margaret C. Egan, Attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Hyatt Hotels (H) director Susan D. Kronick report?

She reported two sales on 09/02/2025: 1,500 shares at a weighted-average price of $141.65 (range $141.13–$142.08) and 100 shares at $142.15.

Were the sales by the Hyatt (H) director part of a 10b5-1 plan?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2024.

How many Hyatt (H) shares did the reporting person beneficially own after the reported sales?

The filing shows beneficial ownership of 36,325 shares following the 1,500-share sale and 36,225 shares following the 100-share sale.

Does the Form 4 provide exact per-transaction prices for the Hyatt sales?

No. The Form 4 provides a weighted-average price and a price range for the 1,500-share sale and a single price for the 100-share sale, but offers to provide full per-price allocation upon request.

Who signed the Form 4 for Susan D. Kronick?

The form was signed by Margaret C. Egan, Attorney-in-fact on 09/03/2025.